UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sex-specific strategies needed to prevent dementia
Men and women have different cardiometabolic risk factors that could lower ...
by Kwak Sung-sun
|
2019-09-20 14:30
라인
Dongwha could lose ₩60 billion sales as GSK ends deal
Dongwha Pharmaceutical faces a steep decrease in sales as GSK Consumer Heal...
by Lee Han-soo
|
2019-09-20 14:28
라인
Novo Nordisk releases trial result for basal insulin analog injection
Novo Nordisk said it has presented the global head-to-head trial called CON...
by Lee Han-soo
|
2019-09-20 12:27
라인
Multinational pharmaceuticals continue to increase R&D spending in Korea
The Korea Research-based Pharma Industry Association (KRPIA) said that the ...
by Lee Han-soo
|
2019-09-19 17:15
라인
Hanmi unveils strong diabetes pipeline at EU meet
Hanmi Pharmaceutical said that it has confirmed the global competitiveness ...
by Lee Han-soo
|
2019-09-19 15:30
라인
Rayence launches low-dose, high-performance X-ray detector
Rayence said Thursday that it has developed a Super IGZO-based high-speed v...
by Lee Han-soo
|
2019-09-19 15:29
라인
‘Galderma Korea ran background checks on unionized workers’
The labor union of Galderma Korea, the local offshoot of a skin healthcare ...
by Jeong Sae-im
|
2019-09-19 15:18
라인
Takeda Korea labor union to ask Japanese headquarters about restructuring
Takeda Pharmaceutical Korea’s trade union, in dispute with management durin...
by Kim Yun-mi
|
2019-09-19 14:11
라인
Chong Kun Dang releases trial result for diabetes treatment
Chong Kun Dang said that it has presented a clinical trial result, which it...
by Lee Han-soo
|
2019-09-19 14:11
라인
Indian biosimilar of rituximab to undergo test in Korea
India’s largest generics drugmaker Dr. Reddy's Laboratories said it wou...
by Lee Hye-seon
|
2019-09-19 10:31
라인
'Multiple sclerosis show more severe symptoms in young people'
Researchers at Seoul National University Hospital have found young patients...
by Lee Han-soo
|
2019-09-18 18:05
라인
Korea unlikely to include hepatitis C test in state-backed health checkup
The government is unlikely to designate a hepatitis C antibody test as a he...
by Kim Yun-mi
|
2019-09-18 15:50
라인
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo
Ono Pharmaceutical and Bristol-Myers Squibb have presented pooled data on t...
by Lee Han-soo
|
2019-09-18 15:48
라인
Macrogen, Psomagen win patent for blockchain technology in US
Macrogen and Psomagen said that they have registered a patent for its block...
by Lee Han-soo
|
2019-09-18 14:36
라인
Regulator delays decision on delisting Kolon TissueGene
The Korea Exchange said it has delayed its decision whether to delist Kolon...
by Jeong Sae-im
|
2019-09-18 14:27
라인
Korea narrows pharmaceutical trade gap in 5 years
Korea's deficit in pharmaceuticals trade has been on the decline for th...
by Lee Han-soo
|
2019-09-18 11:38
라인
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia
CJ Healthcare said that it plans to export K-CAB (Ingredient: tegoprazan), ...
by Lee Han-soo
|
2019-09-18 11:37
라인
Will Tagrisso study results affect use of EGFR TKIs in lung cancer?
AstraZeneca’s imminent announcement of overall survival (OS) data of Tagris...
by Kim Yun-mi
|
2019-09-18 11:36
라인
Hanmi spurs new immunotherapy development through open innovation
Hanmi Pharmaceutical said it is launching new development projects in the f...
by Lee Han-soo
|
2019-09-17 18:14
라인
Government allows new drugs to treat multidrug-resistant TB
The health authorities said they would amend tuberculosis (TB) treatment gu...
by Kim Eun-young
|
2019-09-17 16:28
-
이전
91
92
93
94
95
96
97
98
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top